Atlas

Atlas is a free AI research tool for drug developers preparing INDs. Instead of digging through hundreds of pages of FDA and EMA reviews and US labels, users ask a plain-language question (e.g. "Which species did regulators accept for CD3 bispecifics?") and Atlas returns the closest matching sentences from approved-product reviews, each linked to its source page. Every quote is checked against its source, and where a review is silent on a point, Atlas shows the gap instead of guessing.

Coverage spans approved products across five modalities: bispecifics, antibody-drug conjugates (ADCs), oligonucleotides, gene therapy and cell therapy. Atlas also includes a 36-item pre-IND readiness checklist, a guide to first-in-human dose methods, data on IND clinical holds, a plan benchmarking tool, and alerts when a new approval lands in a chosen modality. Regulator sites are checked weekly, with monthly update emails.

Built for nonclinical/toxicology, regulatory and research leads at biotech companies, as well as consultants and investors.